HARVARD BIOSCIENCE INC — Director's Dealing 2020

Jun 16, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2020-06-12

Reporting Person: EDRICK ALAN I (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-06-12	Common Stock	P	20000	$2.625	Acquired	67500	Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $2.60 to $2.65, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2: Includes (a) a restricted stock unit award with 11,775 remaining unvested restricted stock units vesting in equal quarterly installments on June 30, 2020, September 30, 2020 and December 31, 2020; and (b) 55,725 shares of common stock held by the Reporting Person.